Urinary Biomarkers: Alone Are They Enough?
作者信息
Molitoris Bruce A
机构信息
Nephrology Division, Department of Medicine, Indiana University School of Medicine, Roudebush Veterans Affairs Medical Center, and the Indiana Center for Biological Microscopy, Indianapolis, Indiana
出版信息
J Am Soc Nephrol. 2015 Jul;26(7):1485-8. doi: 10.1681/ASN.2014111145. Epub 2014 Dec 22.
Abstract
摘要
相似文献
1
Urinary Biomarkers: Alone Are They Enough?尿液生物标志物：仅凭它们就足够了吗？
J Am Soc Nephrol. 2015 Jul;26(7):1485-8. doi: 10.1681/ASN.2014111145. Epub 2014 Dec 22.
2
Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.组织金属蛋白酶抑制剂-2（TIMP-2）⋅胰岛素样生长因子结合蛋白-7（IGFBP7）水平与急性肾损伤患者的长期不良预后相关。
J Am Soc Nephrol. 2015 Jul;26(7):1747-54. doi: 10.1681/ASN.2014060556. Epub 2014 Dec 22.
3
Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults.潜在肾损伤暴露后急性肾损伤尿液细胞周期阻滞标志物的动力学。
Crit Care Med. 2018 Mar;46(3):375-383. doi: 10.1097/CCM.0000000000002847.
4
Prognostic value of cell cycle arrest biomarkers in patients at high risk for acute kidney injury: A systematic review and meta-analysis.细胞周期阻滞生物标志物在急性肾损伤高危患者中的预后价值：一项系统评价和荟萃分析。
Nephrology (Carlton). 2017 Nov;22(11):831-837. doi: 10.1111/nep.13095.
5
Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis.尿金属蛋白酶组织抑制剂-2和胰岛素样生长因子结合蛋白7用于脓毒症患者急性肾损伤的风险分层
Crit Care Med. 2016 Oct;44(10):1851-60. doi: 10.1097/CCM.0000000000001827.
6
Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.尿金属蛋白酶组织抑制剂-2（TIMP-2）•胰岛素样生长因子结合蛋白7（IGFBP7）可预测小儿急性肾损伤的不良结局。
PLoS One. 2015 Nov 25;10(11):e0143628. doi: 10.1371/journal.pone.0143628. eCollection 2015.
7
Novel biomarkers to anticipate acute kidney injury. Getting ahead of the curve.预测急性肾损伤的新型生物标志物。抢占先机。
Am J Respir Crit Care Med. 2014 Apr 15;189(8):879-82. doi: 10.1164/rccm.201403-0425ED.
8
Biomarkers. How precise is NephroCheck®?生物标志物。NephroCheck®的精准度如何？
Nat Rev Nephrol. 2015 Mar;11(3):127. doi: 10.1038/nrneph.2015.7. Epub 2015 Feb 3.
9
Biomarkers in Acute Kidney Injury.急性肾损伤中的生物标志物
Crit Care Clin. 2015 Oct;31(4):633-48. doi: 10.1016/j.ccc.2015.06.002. Epub 2015 Jul 29.
10
[Acute kidney injury].[急性肾损伤]
Dtsch Med Wochenschr. 2013 Jun;138(23):1229-32. doi: 10.1055/s-0033-1343183. Epub 2013 May 29.
引用本文的文献
1
CUX1 attenuates the apoptosis of renal tubular epithelial cells induced by contrast media through activating the PI3K/AKT signaling pathway.CUX1 通过激活 PI3K/AKT 信号通路来减轻造影剂诱导的肾小管上皮细胞凋亡。
BMC Nephrol. 2024 Jun 7;25(1):192. doi: 10.1186/s12882-024-03625-8.
2
Risk factors associated with contrast-associated acute kidney injury in ST-segment elevation myocardial infarction patients: a systematic review and meta-analysis.与 ST 段抬高型心肌梗死患者对比剂相关急性肾损伤相关的风险因素：系统评价和荟萃分析。
BMJ Open. 2023 Jun 28;13(6):e070561. doi: 10.1136/bmjopen-2022-070561.
3
Renal MRI: From Nephron to NMR Signal.肾脏 MRI：从肾单位到 NMR 信号。
J Magn Reson Imaging. 2023 Dec;58(6):1660-1679. doi: 10.1002/jmri.28828. Epub 2023 May 26.
4
Continuous diffusion spectrum computation for diffusion-weighted magnetic resonance imaging of the kidney tubule system.肾小管系统扩散加权磁共振成像的连续扩散谱计算
Quant Imaging Med Surg. 2021 Jul;11(7):3098-3119. doi: 10.21037/qims-20-1360.
5
Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury.针对肾脏损伤中未满足的临床需求合理选择生物标志物组合。
Clin Proteomics. 2021 Feb 22;18(1):10. doi: 10.1186/s12014-021-09315-z.
6
Diffusion-weighted Renal MRI at 9.4 Tesla Using RARE to Improve Anatomical Integrity.9.4T 磁共振弥散加权成像应用 RARE 技术提高肾脏解剖完整性。
Sci Rep. 2019 Dec 23;9(1):19723. doi: 10.1038/s41598-019-56184-6.
7
Experimental MRI Monitoring of Renal Blood Volume Fraction Variations to Renal Magnetic Resonance Oximetry.肾脏血容量分数变化对肾脏磁共振血氧测定法的实验性磁共振成像监测
Tomography. 2017 Dec;3(4):188-200. doi: 10.18383/j.tom.2017.00012.
8
Have renal biomarkers failed in acute kidney injury? Yes.肾脏生物标志物在急性肾损伤中是否已告失败？答案是肯定的。
Intensive Care Med. 2017 Jun;43(6):883-886. doi: 10.1007/s00134-017-4759-3. Epub 2017 Apr 24.
9
Understanding and preventing contrast-induced acute kidney injury.理解并预防对比剂诱导的急性肾损伤。
Nat Rev Nephrol. 2017 Mar;13(3):169-180. doi: 10.1038/nrneph.2016.196. Epub 2017 Jan 31.
10
Application of new acute kidney injury biomarkers in human randomized controlled trials.新型急性肾损伤生物标志物在人体随机对照试验中的应用。
Kidney Int. 2016 Jun;89(6):1372-9. doi: 10.1016/j.kint.2016.02.027. Epub 2016 Apr 23.
本文引用的文献
1
Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.组织金属蛋白酶抑制剂-2（TIMP-2）⋅胰岛素样生长因子结合蛋白-7（IGFBP7）水平与急性肾损伤患者的长期不良预后相关。
J Am Soc Nephrol. 2015 Jul;26(7):1747-54. doi: 10.1681/ASN.2014060556. Epub 2014 Dec 22.
2
Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection.用于改善早期抗体介导的肾移植排斥反应风险分层的分子显微镜策略
J Am Soc Nephrol. 2014 Oct;25(10):2267-77. doi: 10.1681/ASN.2013111149. Epub 2014 Apr 3.
3
Urinary biomarkers of AKI and mortality 3 years after cardiac surgery.心脏手术后急性肾损伤和3年死亡率的尿液生物标志物
J Am Soc Nephrol. 2014 May;25(5):1063-71. doi: 10.1681/ASN.2013070742. Epub 2013 Dec 19.
4
Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations*.ICU 中的增强型肾清除率：一项对伴有正常血浆肌酐浓度的危重症患者肾功能的多中心观察性研究结果*。
Crit Care Med. 2014 Mar;42(3):520-7. doi: 10.1097/CCM.0000000000000029.
5
Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.生物标志物在急性肾损伤中的潜在应用：第十届急性透析质量倡议共识会议报告及建议摘要
Kidney Int. 2014 Mar;85(3):513-21. doi: 10.1038/ki.2013.374. Epub 2013 Oct 9.
6
Subclinical AKI--an emerging syndrome with important consequences.亚临床急性肾损伤——一种具有重要后果的新兴综合征。
Nat Rev Nephrol. 2012 Dec;8(12):735-9. doi: 10.1038/nrneph.2012.197. Epub 2012 Sep 25.
7
Imperfect gold standards for kidney injury biomarker evaluation.用于评估肾损伤生物标志物的不完美金标准。
J Am Soc Nephrol. 2012 Jan;23(1):13-21. doi: 10.1681/ASN.2010111124. Epub 2011 Oct 21.
8
Diagnostic value of urinary sodium, chloride, urea, and flow.尿钠、氯、尿素和流量的诊断价值。
J Am Soc Nephrol. 2011 Sep;22(9):1610-3. doi: 10.1681/ASN.2010121289. Epub 2011 Aug 18.
9
Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery.术后生物标志物可预测成人心脏手术后的急性肾损伤和不良结局。
J Am Soc Nephrol. 2011 Sep;22(9):1748-57. doi: 10.1681/ASN.2010121302. Epub 2011 Aug 11.
10
Biological markers of acute kidney injury.急性肾损伤的生物标志物。
J Am Soc Nephrol. 2011 May;22(5):810-20. doi: 10.1681/ASN.2010080796. Epub 2011 Apr 14.
Zotero 插件